Literature DB >> 18415250

[The therapy of pain in rheumatic joint-and spine diseases.].

H Mathies1.   

Abstract

The therapy of pain caused by rheumatic diseases above all must take into consideration the cause of the pain. In rheumatoid arthritis, especially in the early stages, inflammation is the primary cause of the pain. The pain decreases the inflammation subsides following the administration of non-steroidal anti-inflammatory drugs (NSAIDs), or corticosteroids, if necessary. The so-called disease modifying anti-rheumatic drugs do not influence the inflammation or consequently, the pain directly, but rather through mechanisms before the local joint process some of which are not exactly known. In later stages of the progressive joint degeneration the NSAIDs only have a limited effect regarding the inhibition of inflammation. In osteoarthrosis, in which the pain is caused by a secondary inflammation and increasingly by capsular, muscular and tendon involvement, the pain is only treated by NSAIDs in active inflammatory stages; otherwise, the treatment is physical activity and medication. In degenerative and static disorders of the spine the pain is caused predominantly by muscular bracing. Therefore, physical and especially gymnastic therapy play a major role. Whether muscle relaxants have an effect on muscle bracing is doubtful. If there is pressure on the ligaments and, in cases of vertebral dislocation with overstraining of the vertebral joints, therapy with local injections is indicated. The pain in osteoporosis is also predominantly muscular and must be treated accordingly. Above all, high doses of calcium and calcitonin are effective analgesics. Moreover, fluoride also acts as an analgesic once the osteoporosis has stabilized. In most cases fibromyalgia, which is mostly of a psychosomatic nature, cannot be influenced by medical therapy. Instead repeated attempts at treatment help to make the affliction chronic with neurotic fixation. Also, as a rule, myotonolytic and tranquilizing substances are not effective.

Entities:  

Year:  1990        PMID: 18415250     DOI: 10.1007/BF02527876

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  17 in total

1.  Acidic antiinflammatory agents--correlations of some physical, pharmacological and clinical data.

Authors:  J G Lombardino; I G Otterness; E H Wiseman
Journal:  Arzneimittelforschung       Date:  1975-10

Review 2.  The mechanisms of action of nonsteroidal antiinflammatory drugs.

Authors:  S B Abramson; G Weissmann
Journal:  Arthritis Rheum       Date:  1989-01

Review 3.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

4.  Suppression of inflammatory oedema by ibuprofen involving a mechanism independent of cyclo-oxygenase inhibition.

Authors:  M Rampart; T J Williams
Journal:  Biochem Pharmacol       Date:  1986-02-15       Impact factor: 5.858

5.  Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.

Authors:  G Weissmann; P Dukor; R B Zurier
Journal:  Nat New Biol       Date:  1971-06-02

Review 6.  Pharmacokinetics and metabolism of non-steroidal anti-inflammatory drugs.

Authors:  G G Graham
Journal:  Med J Aust       Date:  1987 Dec 7-21       Impact factor: 7.738

Review 7.  [Etiologic and pathogenetic conceptions of arthrosis].

Authors:  P Otte
Journal:  Z Rheumatol       Date:  1983 Jul-Aug       Impact factor: 1.372

8.  Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway.

Authors:  M I Siegel; R T McConnell; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  Anti-inflammatory drugs, prostaglandins and leucocyte migration.

Authors:  J R Walker; M J Smith; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1976-09

10.  Initial kinetics of lysosomal enzyme secretion and superoxide anion generation by human polymorphonuclear leukocytes.

Authors:  J E Smolen; H M Korchak; G Weissmann
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

View more
  2 in total

1.  [Opioids in "non-malignant" pain-results of long-term treatment in patients with rheumatic disease.].

Authors:  J Sorge; B Steffmann; C Lehmkuhl; I Pichlmayr
Journal:  Schmerz       Date:  1991-06       Impact factor: 1.107

2.  [Not Available].

Authors:  J Sorge; H Menninger; U Thoden; E Hackenthal
Journal:  Schmerz       Date:  1992-09       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.